Navigation Links
Study finds patient navigation increases colorectal cancer screening in ethnically diverse patients
Date:5/23/2011

(Boston) Researchers from Boston University School of Medicine, Cambridge Health Alliance and Harvard Medical School have found targeting patient navigation to black and non-English speaking patients may be one approach to reducing disparities in colorectal cancer (CRC) screenings. These findings appear in the May 23 issue of the Archives of Internal Medicine.

Colorectal cancer is the second leading cause of cancer death in the U.S. and is preventable through screening. Nevertheless, about 40 percent of eligible adults in the U.S. and more foreign born U.S. residents are overdue for CRC screening. Patients at greatest risk of not being screened include minorities, patients with Medicaid or no health insurance, those who are foreign-born and patients of low socioeconomic status.

Patient navigators are non-clinical staff members who guide patients through the health care system so that they receive appropriate services. The navigators perform a wide range of advocacy and coordination activities, such as assisting patients in obtaining health insurance or transportation to appointments.

The researchers identified 465 primary care patients from four community health centers and two public hospital-based clinics who were not up-to-date with CRC screening and spoke English, Haitian Creole, Portuguese or Spanish. They randomly allocated patients to receive a patient navigation-based intervention or usual care. Intervention patients received an introductory letter from their primary care provider with educational material followed by telephone calls from a language-concordant navigator. The navigators offered patients the option of being screened by fecal occult blood testing or colonoscopy. The primary outcome was completion of any CRC screening within 12 months. Secondary outcomes included the proportions of patients screened by colonoscopy and who had adenomas or cancer detected.

Over a 12 month period, the researchers found that intervention patients were more likely to undergo CRC screening than control patients (33.6 percent vs. 20.0 percent), to be screened by colonoscopy (26.4 percent vs. 13.0 percent) and to have adenomas detected (8.1 percent vs. 3.9 percent).

"Patient navigation increased CRC screening rates substantially among ethnically and linguistically diverse patients served by urban community health centers and public hospital-based clinics," said lead author Karen Lasser, MD, MPH, an associate professor of medicine and public health at BUSM and Boston University School of Public Health and a primary care physician at Boston Medical Center.

Focusing patient navigation on populations of black and non-English speaking patients may be a particularly effective approach to reducing CRC screening disparities for these patients. Future research should assess how health systems can sustain this benefit when patient navigation is implemented as a routine component of primary care.


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Study links acetaminophen to lower prostate cancer risk
2. Some Dentists Reluctant to Treat Kids on Medicaid: Study
3. Younger Docs More Likely to Prescribe Drugs for Heart Disease: Study
4. Common test could help predict early death in diabetes, study shows
5. Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis
6. EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
7. Robotic Surgery Oversold on Hospital Websites, Study Contends
8. Driving Skills Do Ebb With Age: Study
9. Study Sees Link Between Psoriasis, Obesity in Kids
10. Study Suggests Supplement May Protect Against Preeclampsia
11. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... of African American/Black students who want to become physicians. PMF also provides a ... as physicians in the Oakland/San Francisco Northern California, Bay Area. PMF’s mission is ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... Marc Philpart, senior director at PolicyLink, will be the keynote speaker at its ... Boys and Men of Color Framework, which develops comprehensive strategies to create and ...
(Date:2/21/2017)... ... ... Ray Insurance Agencies, a Dallas area firm providing asset protection services and ... six month charity event aimed at raising local support and donations that will be ... deadliest diseases in America; more than 7.5 million people die from cancer related disorders ...
(Date:2/21/2017)... ... February 21, 2017 , ... Each February ... History Month (officially African American History Month ). This month-long ... of a diverse race of people, but also the opportunity to examine the ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... , Feb. 21, 2017 Medical Oxygen ... report: http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators ... other respiratory diseases. Patients having low level of ... oxygen concentrators. Oxygen concentrators are to be used ... the counter. Medical oxygen concentrators work either on ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring Pharmaceuticals ... the development of innovative immuno-oncology cancer therapies, today ... data from its Phase 2 trial of BeyondSpring,s ... treatment of non-small cell lung cancer (NSCLC) with ... this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
Breaking Medicine Technology: